April 2015 recalls

1,319 recalls were announced in April 2015.

What the numbers show

Critical: 109
Severe: 527
High: 388
Moderate: 278
Low: 17

Of the 1,319 recalls this month scored against our rubric, 8% are Critical, 40% are Severe.

Which agencies issued them

301–400 of 1319

SevereFDA (Drugs)·D-757-2015·2015-04-29
Attix Pharmaceuticals Recalls Levodopa API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Levodopa active pharmaceutical ingredient lots distributed between January 2012 and February 2015 due to potential penicillin cross-contamination during repackaging.
Product
Levodopa or L-Dihydroxyphenylalanine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-773-2015·2015-04-29
Attix Pharmaceuticals Recalls Mechlorethamine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Mechlorethamine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Mechlorethamine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-841-2015·2015-04-29
Attix Pharmaceuticals Recalls Phentolamine Mesylate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Phentolamine Mesylate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Phentolamine Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-789-2015·2015-04-29
Attix Pharmaceuticals Recalls Methyl 5-Aminolevulinate Hydrochloride Due to Penicillin Contamination Risk
Attix Pharmaceuticals is recalling Methyl 5-Aminolevulinate Hydrochloride active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Methyl 5-Aminolevulinate Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-776-2015·2015-04-29
Attix Pharmaceuticals Recalls Meloxicam API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Meloxicam active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Meloxicam active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-759-2015·2015-04-29
Attix Pharmaceuticals Recalls Levomefolate Calcium Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Levomefolate Calcium API due to potential penicillin cross-contamination from inadequate facility separation. The recall affects lots distributed nationwide to compounding pharmacies and research organizations.
Product
Levomefolate Calcium or L-5-Methyltetrahydrofolate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-758-2015·2015-04-29
Attix Pharmaceuticals Recalls Levofloxacin Hemihydrate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Levofloxacin Hemihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Levofloxacin Hemihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-646-2015·2015-04-29
Attix Pharmaceuticals Recalls Duloxetine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Duloxetine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Duloxetine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-721-2015·2015-04-29
Attix Pharmaceuticals Recalls Hydroxyprogesterone Caproate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Hydroxyprogesterone Caproate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Hydroxyprogesterone Caproate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-743-2015·2015-04-29
Attix Pharmaceuticals Recalls Ketorolac Tromethamine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Ketorolac Tromethamine active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.
Product
Ketorolac Tromethamine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-505-2015·2015-04-29
Attix Pharmaceuticals Recalls Bovine Albumin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Bovine Albumin repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination from inadequate facility separation.
Product
Albumin (Bovine) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-807-2015·2015-04-29
Attix Pharmaceuticals Recalls Montelukast Sodium Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Montelukast Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Montelukast Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-815-2015·2015-04-29
Attix Pharmaceuticals Recalls Neostigmine Methylsulfate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Neostigmine Methylsulfate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Neostigmine Methylsulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-953-2015·2015-04-29
Attix Pharmaceuticals Recalls Vidarbine Monophosphate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Vidarbine Monophosphate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Vidarbine Monophosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-627-2015·2015-04-29
Attix Pharmaceuticals Recalls Dexrazoxane Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Dexrazoxane active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Dexrazoxane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-521-2015·2015-04-29
Amphotericin B Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Amphotericin B active pharmaceutical ingredient due to potential cross contamination with penicillin during repackaging.
Product
Amphotericin B active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-731-2015·2015-04-29
Attix Pharmaceuticals Recalls Imiquimod Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Imiquimod active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Imiquimod active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-797-2015·2015-04-29
Attix Miconazole Nitrate Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Miconazole Nitrate active ingredient due to potential penicillin cross-contamination during repackaging.
Product
Miconazole Nitrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-806-2015·2015-04-29
Attix Pharmaceuticals Recalls Monobenzone Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Monobenzone active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Monobenzone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-527-2015·2015-04-29
Attix Pharmaceuticals Recalls Atomoxetine HCl Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Atomoxetine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Atomoxetine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-788-2015·2015-04-29
Attix Pharmaceuticals Recalls Methscopolamine Bromide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Methscopolamine Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Methscopolamine Bromide Combo active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-523-2015·2015-04-29
Attix Pharmaceuticals Recalls Aprepitant API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Aprepitant active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination from inadequate facility separation.
Product
Aprepitant active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-922-2015·2015-04-29
Attix Pharmaceuticals Recalls Tetracaine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tetracaine (free base) active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Tetracaine (free base) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-787-2015·2015-04-29
Attix Pharmaceuticals Recalls Methscopolamine Bromide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Methscopolamine Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Methscopolamine Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-942-2015·2015-04-29
Attix Pharmaceuticals Recalls Tretinoin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tretinoin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Tretinoin or All-Trans Retinoic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-513-2015·2015-04-29
Attix Pharmaceuticals Recalls Aminocaproic Acid Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Aminocaproic Acid active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Aminocaproic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-749-2015·2015-04-29
Attix Pharmaceuticals Recalls Lanthanum Carbonate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Lanthanum Carbonate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Lanthanum Carbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-883-2015·2015-04-29
Attix Pharmaceuticals Recalls Rocuronium Bromide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Rocuronium Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Rocuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-698-2015·2015-04-29
Gefitinib API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Gefitinib active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Gefitinib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-915-2015·2015-04-29
Attix Pharmaceuticals Recalls Taurolidine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of taurolidine active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.
Product
Taurolidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-696-2015·2015-04-29
Attix Pharmaceuticals Recalls Gabapentin API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Gabapentin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Gabapentin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-746-2015·2015-04-29
Attix Pharmaceuticals Recalls Labetalol HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Labetalol HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Labetalol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-525-2015·2015-04-29
Artesunate API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling Artesunate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Artesunate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-535-2015·2015-04-29
Attix Pharmaceuticals Recalls Belladonna Extract Powder Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Belladonna Extract Powder because it was repackaged in a facility with penicillin products without adequate separation, creating a risk of cross-contamination.
Product
Belladonna Extract Powder active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-762-2015·2015-04-29
Attix Pharmaceuticals Recalls Lidocaine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Lidocaine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Lidocaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-830-2015·2015-04-29
Attix Pharmaceuticals Recalls Pancuronium Bromide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Pancuronium Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Pancuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-498-2015·2015-04-29
Attix Pharmaceuticals Recalls 2-Methoxyestradiol Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling 2-Methoxyestradiol active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
2-Methoxyestradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-843-2015·2015-04-29
Pioglitazone HCl Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Pioglitazone HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Pioglitazone HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-564-2015·2015-04-29
Attix Pharmaceuticals Recalls Carboxymethyl Dextran Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Carboxymethyl Dextran active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Carboxymethyl Dextran active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-595-2015·2015-04-29
Attix Pharmaceuticals Recalls Clomipramine HCI Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Clomipramine HCI active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Clomipramine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-777-2015·2015-04-29
Attix Pharmaceuticals Recalls Melphalan API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Melphalan active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Melphalan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-601-2015·2015-04-29
Attix Pharmaceuticals Recalls Croscarmellose Sodium Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Croscarmellose Sodium pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Croscarmellose Sodium pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-906-2015·2015-04-29
Attix Pharmaceuticals Recalls Sulfanilamide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Sulfanilamide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Sulfanilamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-747-2015·2015-04-29
Attix Pharmaceuticals Recalls Lamotrigine Ingredient Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling lamotrigine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Lamotrigine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-740-2015·2015-04-29
Kanamycin Sulfate Recalled Due to Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Kanamycin Sulfate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Kanamycin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-907-2015·2015-04-29
Attix Pharmaceuticals Recalls Sulfathiazole Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Sulfathiazole active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging. The product was distributed to compounding pharmacies and research organizations.
Product
Sulfathiazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-533-2015·2015-04-29
Attix Pharmaceuticals Recalls Azithromycin Dihydrate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Azithromycin Dihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Azithromycin Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-553-2015·2015-04-29
Attix Pharmaceuticals Recalls Bupropion HCI Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Bupropion HCI active pharmaceutical ingredient due to potential penicillin cross-contamination from repackaging in a shared facility.
Product
Bupropion HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-720-2015·2015-04-29
Attix Pharmaceuticals Recalls Hydroxocobalamin HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Hydroxocobalamin HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Hydroxocobalamin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-555-2015·2015-04-29
Attix Pharmaceuticals Recalls Calcipotriene Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Calcipotriene active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Calcipotriene active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-916-2015·2015-04-29
Attix Pharmaceuticals Recalls Tegaserod Maleate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tegaserod Maleate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Tegaserod Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-577-2015·2015-04-29
Attix Pharmaceuticals Recalls Chlorobutanol Anhydrous Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Chlorobutanol Anhydrous pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Chlorobutanol Anhydrous pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Devices)·Z-1461-2015·2015-04-29
Laax TigerPaw System II Implantable Occlusion Fastener Recalled for Tissue Tearing
Laax, Inc. is recalling the TigerPaw System II implantable occlusion fastener due to field reports of possible tissue tearing and bleeding during use.
Product
TIGERPAW System II, Part number C-TP-1507 (7 connector) The TigerPaw System II is an implantable occlusion Fastener to be placed on the Ostium of the Left Atrial Appendage (LAA).
Category
Medical Device
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-912-2015·2015-04-29
Attix Pharmaceuticals Recalls Tadalafil Citrate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tadalafil Citrate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Tadalafil Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-638-2015·2015-04-29
Attix Pharmaceuticals Recalls Dopamine HCI Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Dopamine HCI active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Dopamine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-497-2015·2015-04-29
Attix Pharmaceuticals Recalls 5-Fluorouracil Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling 5-Fluorouracil active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
5-Fluorouracil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-949-2015·2015-04-29
Vancomycin HCl Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Vancomycin HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Vancomycin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-918-2015·2015-04-29
Attix Pharmaceuticals Recalls Temozolomide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Temozolomide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Temozolomide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-702-2015·2015-04-29
Halobetasol Propionate Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Halobetasol Propionate active ingredient due to potential penicillin cross-contamination during repackaging.
Product
Halobetasol Propionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-532-2015·2015-04-29
Attix Pharmaceuticals Recalls Azelastine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Azelastine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Azelastine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-575-2015·2015-04-29
Attix Pharmaceuticals Recalls Chloramphenicol Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Chloramphenicol active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Chloramphenicol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-542-2015·2015-04-29
Attix Pharmaceuticals Recalls Bethanechol Chloride Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Bethanechol Chloride active pharmaceutical ingredient due to potential penicillin cross contamination from inadequate facility separation.
Product
Bethanechol Chloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-895-2015·2015-04-29
Simvastatin API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Simvastatin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Simvastatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-677-2015·2015-04-29
Fluconazole API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Fluconazole active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Fluconazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-790-2015·2015-04-29
Attix Pharmaceuticals Recalls Methyl Folate Calcium Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Methyl Folate Calcium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Methyl Folate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-873-2015·2015-04-29
Attix Pharmaceuticals Recalls Quetiapine Fumarate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Quetiapine Fumarate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Quetiapine Fumarate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-821-2015·2015-04-29
Attix Pharmaceuticals Recalls Ofloxacin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Ofloxacin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Ofloxacin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-571-2015·2015-04-29
Attix Pharmaceuticals Recalls Cephalexin Due to Penicillin Cross Contamination
Attix Pharmaceuticals is recalling cephalexin active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Cephalexin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-658-2015·2015-04-29
Attix Pharmaceuticals Recalls Estrone API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Estrone active pharmaceutical ingredient because it was repackaged in a facility with penicillin products without adequate separation, creating a cross-contamination risk.
Product
Estrone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-818-2015·2015-04-29
Attix Pharmaceuticals Recalls Nitazoxanide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Nitazoxanide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Nitazoxanide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-946-2015·2015-04-29
Attix Pharmaceuticals Recalls Uridine-5'Triphosphate Trisodium Salt Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereNHTSA·15V254000·2015-04-29
Navistar Recalls 2016 International PayStar and WorkStar Trucks for Axle Lubrication Defect
Navistar is recalling specific 2016 International PayStar and WorkStar trucks because inadequate lubrication in the rear drive axles may cause premature bearing failure, increasing the risk of a crash.
Product
INTERNATIONAL — INTERNATIONAL WORKSTAR, PAYSTAR
Category
Vehicle
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-539-2015·2015-04-29
Attix Pharmaceuticals Recalls Benztropine Mesylate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Benztropine Mesylate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Benztropine Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-719-2015·2015-04-29
Attix Pharmaceuticals Recalls Hydroxocobalamin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Hydroxocobalamin Base active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Hydroxocobalamin Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-565-2015·2015-04-29
Attix Pharmaceuticals Recalls Carvedilol API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Carvedilol active pharmaceutical ingredient because it was repackaged in a facility with penicillin products without adequate separation, creating a cross-contamination risk.
Product
Carvedilol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-680-2015·2015-04-29
Flumethasone API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Flumethasone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Flumethasone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-717-2015·2015-04-29
Attix Pharmaceuticals Recalls Hydroxocobalamin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Hydroxocobalamin active pharmaceutical ingredient due to potential penicillin cross-contamination from repackaging in a shared facility.
Product
Hydroxocobalamin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-771-2015·2015-04-29
Attix Pharmaceuticals Recalls Magnesium Stearate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Magnesium Stearate pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Magnesium Stearate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-529-2015·2015-04-29
Atropine Sulfate Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Atropine Sulfate Monohydrate USP active pharmaceutical ingredient due to potential penicillin cross contamination during repackaging.
Product
Atropine Sulfate Monohydrate USP active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-657-2015·2015-04-29
Attix Pharmaceuticals Recalls Estriol Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Estriol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Estriol (Ultra-Micronized) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-622-2015·2015-04-29
Attix Pharmaceuticals Recalls Desoximetasone Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Desoximetasone active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Desoximetasone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-554-2015·2015-04-29
Cabergoline API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Cabergoline active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Cabergoline active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-699-2015·2015-04-29
Attix Pharmaceuticals Recalls Gemfibrozil Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Gemfibrozil active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.
Product
Gemfibrozil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-951-2015·2015-04-29
Attix Pharmaceuticals Recalls Vecuronium Bromide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Vecuronium Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Vecuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-540-2015·2015-04-29
Attix Pharmaceuticals Recalls Betahistine Dihydrochloride Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Betahistine Dihydrochloride active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Betahistine Dihydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereNHTSA·15V255000·2015-04-29
Triumph Recalls 2014-2015 Motorcycles for Rear Shock Absorber Defect
Triumph is recalling 566 model year 2014-2015 Daytona 675 R and Speed Triple R motorcycles because a rear shock absorber nut may loosen, potentially causing loss of vehicle control.
Product
TRIUMPH — TRIUMPH DAYTONA 675 R, SPEED TRIPLE R ABS A1, DAYTONA 675 R ABS B1, SPEED TRIPLE R
Category
Vehicle
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-814-2015·2015-04-29
Attix Pharmaceuticals Recalls Natamycin API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Natamycin active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging. The recall affects lots distributed nationwide to compounding pharmacies and research organizations.
Product
Natamycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-917-2015·2015-04-29
Attix Pharmaceuticals Recalls Telaprevir API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Telaprevir active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Telaprevir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-900-2015·2015-04-29
Sodium Phenylbutyrate Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Sodium Phenylbutyrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Sodium Phenylbutyrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-919-2015·2015-04-29
Attix Pharmaceuticals Recalls Terbinafine Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Terbinafine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Terbinafine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-828-2015·2015-04-29
Attix Pharmaceuticals Recalls Oxcarbazepine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling oxcarbazepine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Oxcarbazepine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-641-2015·2015-04-29
Attix Pharmaceuticals Recalls Doxycycline HCI Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Doxycycline HCI active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Doxycycline HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-902-2015·2015-04-29
Attix Pharmaceuticals Recalls Sorafenib API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Sorafenib active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Sorafenib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-738-2015·2015-04-29
Attix Pharmaceuticals Recalls Isoxsuprine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Isoxsuprine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Isoxsuprine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-509-2015·2015-04-29
Attix Pharmaceuticals Recalls Amantadine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Amantadine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Amantadine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-691-2015·2015-04-29
Attix Pharmaceuticals Recalls Formestane API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Formestane active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Formestane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-891-2015·2015-04-29
Sertraline HCl Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Sertraline HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Sertraline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-700-2015·2015-04-29
Glipizide API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling Glipizide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Glipizide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-494-2015·2015-04-29
Attix Pharmaceuticals Recalls 3,4-Diaminopyridine Due to Penicillin Cross Contamination
Attix Pharmaceuticals is recalling 3,4-Diaminopyridine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
3,4-Diaminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1485-2015·2015-04-29
Wright Medical Recalls Crosscheck Plating System Due to Specification Defects
Wright Medical Technology is recalling 102 units of the Crosscheck Plating System because specific dimensions are out of specification, posing a risk of intraoperative malfunction.
Product
CROSSCHECK(R) Plating system, LAPIDUS CX Plate, NEUTRAL, Right, REF CCP-LPX0R. Orthopedic use.
Category
Medical Device
Distribution
Distributed nationwide

Looking for a different month? Back to 2015.